通过阿尔茨海默氏病测序项目 (Alzheimer's Disease Sequencing Project) 的全基因组测序数据的关键变异
Yanbing Wang1, Chloé Sarnowski1,2, Honghuang Lin3
1Department of Biostatistics, Boston University, School of Public Health, Boston, Massachusetts, USA.
概括
全基因组测序 (WGS) 在之前识别的GWAS位置内确定了与阿尔茨海默病 (AD) 相关的十七种变异. 这种方法提高了对AD遗传风险因素的理解.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
背景情况:
- 全基因组关联研究 (GWAS) 已经确定了阿尔茨海默病 (AD) 位点,但没有发现因果变异.
- 全基因组测序 (WGS) 可以在这些位置内识别罕见的变异和因果变异.
研究的目的:
- 使用WGS数据在AD相关的位置内识别因果变异.
- 利用WGS数据了解阿尔茨海默病遗传风险因素.
主要方法:
- 在阿尔茨海默氏病测序项目 (ADSP) 的WGS数据上进行单个常见变异和罕见变异的综合分析.
- 集中分析的变体在100kB以内的83个先前识别的GWAS变体.
- 针对目标分析使用了一个聚合的群体 (N病例=2184,N对照=2383) 和子群体.
主要成果:
- 在五个基因组区域内确定了17种与阿尔茨海默氏症显著相关的变异.
- 涉及的基因包括OARD1/NFYA/TREML1,JAZF1,FERMT2,SLC24A4和KAT8.8这些基因.
- 单个变异和罕见变异综合分析都涉及KAT8.
结论:
- 证明了WGS在确定阿尔茨海默病GWAS位点内的因果变异中的实用性.
- 通过精细地绘制GWAS区域,提供了对阿尔茨海默病遗传结构的见解.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.7K
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
11.8K
相关概念视频
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
